Ovulation induction in the era of recombinant gonadotropins and GnRH analogues.
Insler
V
V
Department of Obstetrics and Gynecology, Kaplan Hospital, Rehovot, Israel.
Lunenfeld
B
B
D000818:Animals; D002460:Cell Line; D006224:Cricetinae; D003412:Cricetulus; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors; D006062:Gonadotropins / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007247:Infertility, Female / Q000188:drug therapy; D008297:Male; D008991:Monitoring, Physiologic; D010053:Ovary / Q000166:cytology; D010062:Ovulation Induction; D018579:Patient Selection; D011247:Pregnancy; D011256:Pregnancy Outcome; D011272:Pregnancy, Multiple; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012744:Sex Ratio; D013480:Superovulation; D013552:Swine; D013997:Time Factors
D006062:Gonadotropins; D011994:Recombinant Proteins; D007987:Gonadotropin-Releasing Hormone